Tsao H, Benoit E, Sober AJ, Thiele C, Haluska FG.
Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 gene.
Cancer Res 1998; 58: 109-113.

Tsao H, Rogers GS, Sober AJ.
An estimate of the annual direct cost of treatig cutaneous melanoma
J Am Acad Dermatol 1998; 38: 669-680.

Tsao H, Zhang X, Benoit E, Haluska FG.
Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
Oncogene 1998; 16: 3397-3402.

Tsao H, Zhang X, Majewski P, Haluska FG.
Mutational and expression analysis of the p73 gene in melanoma cell lines.
Cancer Res 1999; 59: 172-174.

Tsao H, Zhang X, Fowlkes K, Haluska FG.
Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.
Cancer Res 2000; 60: 1800-4.

Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ, Haluska FG.
Low prevalence of germline CDKN2A and CDK4 mutations in patients with early onset melanoma.
Arch Dermatol, 2000; 136: 1118-1122.

Tsao H. CME
Article: Update on familial cancer syndromes and the skin.
J Am Acad Dermatol 2000; 42: 939-969.

Tsao H, Nadiminti U, Sober AJ, Bigby M.
A meta-analysis of reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma.
Arch Dermatol, 2001; 137:325-330.

Goggins W, Finkelstein D, Tsao H.
Evidence for an association between cutaneous melanoma and non-Hodgkin's lymphoma.
Cancer, 2001; 91:874-80.

Niendorf KB, Shannon KM. The role of genetic testing and effect on patient care. Arch Dermatol. 2001 Nov;137(11):1515-9. 11. Sober AJ, Chuang TY, Duvic M, Farmer ER, Grichnik JM, Halpern AC, Ho V, Holloway V, Hood AF, Johnson TM, Lowery BJ;
Guidelines/Outcomes Committee. Guidelines of care for primary cutaneous melanoma.
J Am Acad Dermatol. 2001 Oct;45(4):579-86.

Tsao H.
Genetics of non-melanoma skin cancer.
Arch Dermatol; 2001; 137: 1486-1492

Tsao H, Kwitkiwski K, Sober AJ.
A single-institution case series of patients with cutaneous melanoma and non-Hodgkin's lymphoma.
J Am Acad Dermatol; 2002; 46:55-61

Tsao H, Millman P, Linette GP, Hodi FS, Sober AJ, Goldberg MA, Haluska FG.
Hypopigmentation associated with an adenovirus-mediated gp100/MART-1-transduced dendritic cell vaccine for metastatic melanoma.
Arch Dermatol. 2002;138:799-802.

Goggins WB, Tsao H.
A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors.
Cancer 2003;97:639-43

Tsao H, Bevona C, Goggins W, Quinn T.
The transformation rate of moles (melanocytic nevi) into cutaneous melanoma.
Arch Dermatol 2003;139:282-8.

Tsao H, Mihm MC, Sheehan C.
PTEN expression in normal skin, acquired melanocytic nevi and cutaneous melanoma.
J Am Acad Dermatol 2003; 49(5):865-72

Bevona C, Goggins W, Quinn T, Fullerton J, Tsao H.
Cutaneous melanomas associated with nevi.
Arch Dermatol 2003;139:1620-4

[21]. Bevona C, Sober AJ, Tsao H Chapter 15.
Childhood melanoma. In: Balch C, Houghton AN, Sober AJ, Soong SJ, eds. Cutaneous Melanoma 6th Edition.
St Louis: Quality Medical Publishing, Inc, 2003: 309-318

Tsao H, Sober AJ. Chapter 91.
Atypical Melanocytic Nevi. In: Fitzpatrick TB, et al, eds. Fitzpatrick's Dermatology in General Medicine, 6th Edition.
New York, NY: McGraw Hill, Inc., 2003: 906-916

Tsao H, Feldman M, Fullerton JE, Sober AJ, Rosenthal D, Goggins W.
Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival.
Arch Dermatol 2004;140:67-70.

Tsao H, Goel V, Wu H, Yang G, Haluska FG.
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
J Invest Dermatol 2004;122:337-41

Goggins W, Gao W, Tsao H.
Association between female breast cancer and cutaneous melanoma.
Int J Cancer. 2004;111:792-4.

Yang G, Niendorf KB, Tsao H.
A novel methionine-53-valine mutation of p16 in a hereditary melanoma kindred.
J Invest Dermatol. 2004;123:574-5

Tsao H, Atkins MB, Sober AJ.
Management of cutaneous melanoma.
N Engl J Med. 2004;351:998-1012.